Jean–Claude Reubi

4.8k total citations · 1 hit paper
60 papers, 3.8k citations indexed

About

Jean–Claude Reubi is a scholar working on Epidemiology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jean–Claude Reubi has authored 60 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Epidemiology, 26 papers in Oncology and 17 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jean–Claude Reubi's work include Neuroendocrine Tumor Research Advances (47 papers), Lung Cancer Research Studies (21 papers) and Radiopharmaceutical Chemistry and Applications (15 papers). Jean–Claude Reubi is often cited by papers focused on Neuroendocrine Tumor Research Advances (47 papers), Lung Cancer Research Studies (21 papers) and Radiopharmaceutical Chemistry and Applications (15 papers). Jean–Claude Reubi collaborates with scholars based in Switzerland, Netherlands and Germany. Jean–Claude Reubi's co-authors include Eric P. Krenning, Jean A. Laissue, Steven W. J. Lamberts, Jean Rivier, Wylie Vale, Marilyn H. Perrin, Dik J. Kwekkeboom, Beatrice Waser, Helmut R. Maëcke and Damian Wild and has published in prestigious journals such as New England Journal of Medicine, JAMA and Gastroenterology.

In The Last Decade

Jean–Claude Reubi

59 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors

1991 680 citations Eric P. Krenning, Jean–Claude Reubi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jean–Claude Reubi Switzerland	35	2.3k	1.5k	1.1k	1.1k	822	60	3.8k
Jean‐Claude Schaer Switzerland	21	1.6k 0.7×	1.3k 0.9×	716 0.6×	708 0.7×	370 0.5×	39	2.7k
Flavio Forrer Switzerland	27	1.3k 0.6×	1.2k 0.8×	1.4k 1.2×	634 0.6×	264 0.3×	51	2.9k
Renzo Cescato Switzerland	25	1.5k 0.6×	1.5k 1.0×	1.4k 1.2×	506 0.5×	167 0.2×	46	2.7k
K. Kitz Austria	32	1.8k 0.8×	397 0.3×	297 0.3×	1.1k 1.0×	1.5k 1.9×	91	4.0k
Károly Szepesházi United States	35	821 0.4×	1.2k 0.8×	299 0.3×	236 0.2×	941 1.1×	96	3.1k
Yoko Nakasu Japan	30	637 0.3×	709 0.5×	289 0.3×	705 0.7×	270 0.3×	145	2.7k
Jens Schittenhelm Germany	36	826 0.4×	463 0.3×	1.0k 0.9×	905 0.9×	222 0.3×	190	4.7k
Adelheid Wöhrer Austria	31	645 0.3×	831 0.5×	372 0.3×	475 0.5×	494 0.6×	79	3.7k
Ghazaleh Tabatabai Germany	38	1.1k 0.5×	836 0.5×	820 0.7×	724 0.7×	160 0.2×	183	5.3k
Norio Arita Japan	34	449 0.2×	572 0.4×	182 0.2×	605 0.6×	660 0.8×	137	3.5k

Countries citing papers authored by Jean–Claude Reubi

Since Specialization

Citations

This map shows the geographic impact of Jean–Claude Reubi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean–Claude Reubi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean–Claude Reubi more than expected).

Fields of papers citing papers by Jean–Claude Reubi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean–Claude Reubi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean–Claude Reubi. The network helps show where Jean–Claude Reubi may publish in the future.

Co-authorship network of co-authors of Jean–Claude Reubi

This figure shows the co-authorship network connecting the top 25 collaborators of Jean–Claude Reubi. A scholar is included among the top collaborators of Jean–Claude Reubi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean–Claude Reubi. Jean–Claude Reubi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wicki, Andreas, Damian Wild, Rosalba Mansi, et al.. (2014). Synergism of peptide receptor-targeted Auger electron radiation therapy with anti-angiogenic compounds in a mouse model of neuroendocrine tumors. EJNMMI Research. 4(1). 9–9. 4 indexed citations

Wild, Damian, Hanwen Zhang, Aliyah Morgenstern, et al.. (2011). Alpha- versus Beta-Particle Radiopeptide Therapy in a Human Prostate Cancer Model (213Bi-DOTA-PESIN and 213Bi-AMBA versus177Lu-DOTA-PESIN). Cancer Research. 71(3). 1009–1018. 105 indexed citations

Guggenberg, Elisabeth von, Christine Rangger, Jane Sosabowski, et al.. (2011). Preclinical Evaluation of Radiolabeled DOTA-Derivatized Cyclic Minigastrin Analogs for Targeting Cholecystokinin Receptor Expressing Malignancies. Molecular Imaging and Biology. 14(3). 366–375. 28 indexed citations

Öberg, Kjell E., Jean–Claude Reubi, Dik J. Kwekkeboom, & Eric P. Krenning. (2010). Role of Somatostatins in Gastroenteropancreatic Neuroendocrine Tumor Development and Therapy. Gastroenterology. 139(3). 742–753.e1. 142 indexed citations

Hayes, Gregory M., Patricia E. Carrigan, Maoqing Dong, Jean–Claude Reubi, & Laurence J. Miller. (2007). A Novel Secretin Receptor Splice Variant Potentially Useful for Early Diagnosis of Pancreatic Carcinoma. Gastroenterology. 133(3). 853–861. 8 indexed citations

Storch, Daniel D., et al.. (2007). Preclinical evaluation of somatostatin analogs bearing two macrocyclic chelators for high specific activity labeling with radiometals. Radiochimica Acta. 95(6). 359–369. 3 indexed citations

Wicki, Andreas, Damian Wild, Daniel D. Storch, et al.. (2007). [Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 Is a Highly Efficient Radiotherapeutic for Glucagon-Like Peptide-1 Receptor–Targeted Therapy for Insulinoma. Clinical Cancer Research. 13(12). 3696–3705. 73 indexed citations

Reubi, Jean–Claude, et al.. (2005). Three‐year recurrence‐free survival in a patient with recurrent medulloblastoma after resection, high‐dose chemotherapy, and intrathecal Yttrium‐90‐labeled DOTA⁰‐D‐Phe¹‐Tyr³‐octreotide radiopeptide brachytherapy. Cancer. 103(4). 869–873. 20 indexed citations

Krenning, Eric P., Roelf Valkema, Dik J. Kwekkeboom, et al.. (2005). Molecular imaging as in vivo molecular pathology for gastroenteropancreatic neuroendocrine tumors: implications for follow-up after therapy.. PubMed. 46 Suppl 1. 76S–82S. 33 indexed citations

10.

Wild, Damian, Jörg Schmitt, Mihaela Ginj, et al.. (2003). DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals. European Journal of Nuclear Medicine and Molecular Imaging. 30(10). 1338–1347. 230 indexed citations

11.

Wester, Hans‐Jürgen, Margret Schottelius, Klemens Scheidhauer, et al.. (2002). Comparison of radioiodinated TOC, TOCA and Mtr-TOCA: the effect of carbohydration on the pharmacokinetics. European Journal of Nuclear Medicine and Molecular Imaging. 29(1). 28–38. 47 indexed citations

12.

Hessenius, Carsten, Michael Bäder, H. Meinhold, et al.. (2000). Vasoactive intestinal peptide receptor scintigraphy in patients with pancreatic adenocarcinomas or neuroendocrine tumours. European Journal of Nuclear Medicine and Molecular Imaging. 27(11). 1684–1693. 28 indexed citations

13.

Krenning, Eric P., Dik J. Kwekkeboom, Stanislas Pauwels, Larry K. Kvols, & Jean–Claude Reubi. (1994). The Role of Somatostatin Receptor Scintigraphy in Gastroenteropancreatic Endocrine Tumors. Digestive Surgery. 11(3-6). 456–460.

14.

Kho, G.S., et al.. (1994). The value of octreotide scintigraphy in patients with lung cancer. European Journal of Nuclear Medicine and Molecular Imaging. 21(10). 1106–13. 86 indexed citations

15.

Moertel, Christopher L., et al.. (1994). Expression of Somatostatin Receptors in Childhood Neuroblastoma. American Journal of Clinical Pathology. 102(6). 752–756. 57 indexed citations

16.

Lamberts, Steven W. J., Jean–Claude Reubi, & Eric P. Krenning. (1993). Validation of Somatostatin Receptor Scintigraphy in the Localization of Neuroendocrine Tumors. Acta Oncologica. 32(2). 167–170. 25 indexed citations

17.

Moran, Antoinette, L. Sylvia, Kálmán Kovács, et al.. (1990). Gigantism Due to Pituitary Mammosomatotroph Hyperplasia. New England Journal of Medicine. 323(5). 322–327. 51 indexed citations

18.

Levy, Andrew, D.J.A. Eckland, Alison M. Gurney, et al.. (1989). Somatostatin and Thyrotrophin‐Releasing Hormone Response and Receptor Status of a Thyrotrophin‐Secreting Pituitary Adenoma: Clinical and in vitro Studies. Journal of Neuroendocrinology. 1(5). 321–326. 25 indexed citations

19.

Lamberts, Steven W. J., André G. Uitterlinden, Jean–Claude Reubi, & Frank H. de Jong. (1989). Effects of Gonadotropin-Releasing Hormone and Its Agonists on Prolactin Secretion from Normal and Tumorous Pituitary Cells. Neuroendocrinology. 49(2). 157–163. 3 indexed citations

20.

Reubi, Jean–Claude, Jean Rivier, Marilyn H. Perrin, Marvin R. Brown, & Wylie Vale. (1982). SPECIFIC HIGH AFFINITY BINDING SITES FOR SOMATOSTATIN-28 ON PANCREATIC 6-CELLS:DIFFERENCES WITH BRAIN SOMATOSTATIN RECEPTORS1. Endocrinology. 110(3). 1049–1051. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact